热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
Purified anti-mouse/human CD11b Antibody
产品名称：
Purified anti-mouse/human CD11b Antibody
产品类别：
抗体
产品编号：
101201
产品应用：
101201
[价格]
规格 价格 库存
50µg ￥ 360 1

产品详情

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F, CyTOF? - Verified
IP, ICC - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?L volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone M1/70 has been verified for?immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) (Cat. No. 101248).

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  36. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  2. Kobayashi A, et al. 2021. Front Immunol. 12:650856. PubMed
  3. Paterson MJ, et al. 2020. PLoS Pathog. 16:e1008733. PubMed
  4. Peterson EJ, et al. 2019. Mol Syst Biol. 15:e8584. PubMed
  5. Axelrod HD, et al. 2019. Mol Cancer Res. 17:356. PubMed
  6. Tong CF, et al. 2018. Am J Physiol Cell Physiol. 315:C409. PubMed
  7. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  8. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  9. Taki M, et al. 2018. Nat Commun. 1.545138889. PubMed
  10. Vinaik R, et al. 2019. Am J Physiol Endocrinol Metab. 317:E751. PubMed
  11. Yonemitsu K, et al. 2022. Sci Rep. 12:12007. PubMed
  12. Pilling D, et al. 2022. Respir Res. 23:215. PubMed
  13. Baja?a S, et al. 2021. Front Immunol. 11:577718. PubMed
  14. Zhao J, et al. 2021. JCI Insight. 6:. PubMed
  15. Larson-Casey JL, et al. 2021. FASEB J. 35:e21675. PubMed
  16. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  17. Reglero-Real N, et al. 2021. Immunity. :. PubMed
  18. Weidner H, et al. 2020. JCI Insight. 5:00. PubMed
  19. Kim D, et al. 2008. Blood. 112:1109. PubMed
  20. Mazor R, et al. 2018. Proc Natl Acad Sci U S A. 115:E733. PubMed
  21. Chung MI, et al. 2018. Am J Respir Cell Mol Biol. 59:706. PubMed
  22. Burrello C, et al. 2018. Front Med (Lausanne). 5:21. PubMed
  23. Chartrand K, et al. 2018. Front Immunol. 1.642361111. PubMed
  24. Shirakawa K, et al. 2017. PLoS One. 12:e0186303. PubMed
  25. Zhou LJ et al. 2019. Cell Rep. 27(13):3844-3859 . PubMed
  26. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  27. Leyva-Castillo JM, et al. 2020. Clin Immunol. 218:108511. PubMed
  28. Bachran C, et al. 2017. Sci Rep.. 10.1038/s41598-017-17948-0. PubMed
  29. Wagner J et al. 2019. Cell. 177(5):1330-1345 . PubMed
  30. Peng J, et al. 2019. Mol Brain. 12:71. PubMed
  31. Ajona D, et al. 2017. Cancer Discov. 0.773611111. PubMed
  32. Goel S, et al. 2017. Nature. 548:471. PubMed
  33. Tang B, et al. 2019. Oncolytic Virother. 8:03. PubMed
  34. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  35. Arnold IC, et al. 2018. J Exp Med. 215:2055. PubMed
  36. Dertschnig S, et al. 2020. J Clin Invest. 130:1896. PubMed
  37. Dienz O, et al. 2020. J Immunol. 204:1521. PubMed
  38. Nguyen N, et al. 2022. iScience. 25:103679. PubMed
  39. Karhadkar TR, et al. 2021. J Pharmacol Exp Ther. 376:106. PubMed
  40. Rogic A, et al. 2021. Nat Commun. 12:6889. PubMed
  41. Chen L, et al. 2019. Nat Commun. 3.553472222. PubMed
  42. Cao Q, et al. 2018. Am J Physiol Renal Physiol. 314:F561. PubMed
  43. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  44. Bredeh?ft J, et al. 2022. J Inflamm Res. 15:509. PubMed
  45. Tian D, et al. 2020. FASEB J. 34:3367. PubMed
  46. Stefanescu C, et al. 2021. Front Oncol. 11:765151. PubMed
  47. Peng J, et al. 2016. Nat Commun. 7:12029. PubMed
  48. Dave K et al. 2017. eLife. 6 pii: e23382. PubMed
  49. Arimura K, et al. 2017. Mucosal Immunol. 1.08125. PubMed
  50. Liu T, et al. 2020. Sci Adv. 6:eaay1497. PubMed
  51. Lee JH, et al. 2022. iScience. 25:104166. PubMed
  52. Delgobo M, et al. 2021. Front Immunol. 12:584538. PubMed
  53. Tal MC, et al. 2020. MBio. 11:00. PubMed
  54. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  55. Haney MS, et al. 2018. Nat Genet. 50:1716. PubMed
  56. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  57. Rissiek B, et al. 2017. Sci Rep. . 10.1038/s41598-017-16613-w. PubMed
  58. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
  59. Si Y, et al. 2020. Sci Adv. 6:eaaw7713. PubMed
  60. O'Dea KP, et al. 2020. J Extracell Vesicles. 9:1706708. PubMed
  61. Matsuhira T, et al. 2021. Biochem Biophys Rep. 28:101118. PubMed
  62. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  63. Yan J, et al. 2020. Cancer Immunol Res. 8:356. PubMed
  64. Gomi M, et al. 2021. Mol Ther. 29:225. PubMed
  65. Chen L, et al. 2020. Front Immunol. 11:584458. PubMed
  66. Nolin JD, et al. 2017. JCI Insight. 2:e94929. PubMed
  67. Chen S, et al. 2018. Immunohorizons. 0.345138889. PubMed
  68. Yang C, et al. 2019. MBio. 10:e00595-19. PubMed
  69. Silvestre-Roig C, et al. 2019. Nature. 569:236. PubMed
  70. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  71. Guiducci E, et al. 2018. Front Immunol. 1.467361111. PubMed
  72. Guo Y, et al. 2008. Blood. 112:480. PubMed
  73. He LD, et al. 2021. EMBO Rep. 22:e52196. PubMed
  74. Sun Y, et al. 2022. Nat Commun. 13:3916. PubMed
  75. Karhadkar TR, et al. 2021. PLoS One. 16:e0245924. PubMed
  76. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  77. Zhao L, et al. 2018. Nat Med. 24:1536. PubMed
  78. Manni M, et al. 2018. Nat Immunol. 1.074305556. PubMed
  79. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  80. Lai JF, et al. 2020. J Allergy Clin Immunol. 146:1406. PubMed
  81. Vukman KV, et al. 2020. J Extracell Vesicles. 10:e12023. PubMed
  82. Jiang L, et al. 2022. Front Immunol. 12:730438. PubMed
  83. Sato Y, et al. 2021. BMC Cancer. 21:1222. PubMed
  84. Liu H, et al. 2020. J Immunol. 205:1207. PubMed
  85. Muraleedharan A, et al. 2021. Glia. 69:697. PubMed
  86. Bednarczyk M, et al. 2021. Int J Mol Sci. 22:. PubMed
  87. Shokirova H, et al. 2021. Sci Rep. 11:8647. PubMed
  88. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  89. Francis M, et al. 2017. Toxicol Sci. 155(1):182-195. PubMed
  90. Gartlan KH, et al. 2019. Blood Adv. 2.110416667. PubMed
  91. Abboud G, et al. 2018. Front Immunol. 9:1973. PubMed
  92. Napimoga M, et al. 2008. J Immunol. 180:609. PubMed
  93. Hakamivala A, et al. 2020. Bioact Mater. 5:142. PubMed
  94. Zhong X, et al. 2020. Proc Natl Acad Sci U S A. 8563:117. PubMed
  95. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  96. Wei S, et al. 2019. Virulence. 0.588888889. PubMed
  97. Kapellos TS, et al. 2017. Mediators Inflamm. 2017:4315412. PubMed
  98. Umemoto T, et al. 2017. EMBO J. 36:2390. PubMed
  99. Kim SJ, et al. 2017. Nat Immunol. 18:1016. PubMed
  100. Tsubaki T, et al. 2018. Oncotarget. 9:11209. PubMed
  101. Wicki S, et al. 2018. Int J Mol Sci. 1.266666667. PubMed
  102. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  103. Krueger A, et al. 2022. Front Microbiol. 12:789042. PubMed
  104. Johnson SA, et al. 2021. Eur J Immunol. 51:3228. PubMed
  105. Manabe T, et al. 2021. J Neurochem. 159:525. PubMed
  106. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  107. Lim CS, et al. 2020. Front Immunol. 11:1186. PubMed
  108. Yoon S, et al. 2020. Antioxidants (Basel). 10:. PubMed
  109. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  110. You X, et al. 2022. Front Genet. 12:790990. PubMed
  111. Coden ME, et al. 2020. J Immunol. 204:438. PubMed
  112. Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed
  113. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  114. Paharik AE, et al. 2017. Cell Host Microbe. 22:746. PubMed
  115. Nascimento DC, et al. 2017. Nat Commun. 8:14919. PubMed
  116. Shin J, et al. 2018. Diabetes. 67:1068. PubMed
  117. Majer O, et al. 2019. Nature. 575:366. PubMed
  118. Chen HW, et al. 2021. Biomedicines. 9:. PubMed
  119. Karhadkar TR, et al. 2020. bioRxiv. . PubMed
  120. Huang S, et al. 2020. Cell Rep. 33:108394. PubMed
  121. Daley D, et al. 2017. Nat Med. 23:556. PubMed
  122. Hsieh JY, et al. 2019. APL Bioeng. 3:016103. PubMed
  123. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  124. Yi MH, et al. 2020. Brain Behav Immun. 92:78. PubMed
  125. Meyer-Lindemann U, et al. 2022. Front Immunol. 13:898690. PubMed
  126. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  127. Li J, et al. 2021. Front Immunol. 12:710406. PubMed
  128. Madsen D, et al. 2017. Cell Rep.. 10.1016/j.celrep.2017.12.011. PubMed
  129. Fino KK, et al. 2017. Sci Rep. 5.334722222. PubMed
  130. Yoon BH, et al. 2018. Mol Cells. 41:953. PubMed
  131. Hoffmann FM, et al. 2018. Front Immunol. 9:1046. PubMed
  132. Baumgartner C, et al. 2010. J Immunol. 184:573. PubMed
  133. Nguyen CH, et al. 2020. Biomedicines. 8:. PubMed
  134. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  135. Speir M, et al. 2020. Nat Immunol. 21:54. PubMed
  136. Kikuchi A, et al. 2020. Am J Pathol. 190:2080. PubMed
  137. Freeman SA, et al. 2020. Science. 367:301. PubMed
  138. Galbas T, et al. 2017. J Immunol. 198(2):852-861. PubMed
  139. Kim D, et al. 2019. Immune Netw. 19:e32. PubMed
  140. Kawabe T, et al. 2017. Sci Immunol. 2:eaam9315. PubMed
  141. Ding L, et al. 2022. Nanoscale. . PubMed
  142. Scortegagna M, et al. 2020. Nat Commun. 11:99. PubMed
  143. Vahsen BF, et al. 2022. Sci Rep. 12:12606. PubMed
  144. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  145. Akiel M, et al. 2017. Cancer Res. 77:4014. PubMed
  146. Wang Y, et al. 2019. Biomed Res Int. 2019:5756189. PubMed
  147. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  148. Elgazar-Carmon V, et al. 2008. J Lipid Res. 49:1849. PubMed
  149. Düking T, et al. 2022. Sci Adv. 8:eabo7639. PubMed
  150. Wu W, et al. 2020. Brain Behav Immun. 89:245. PubMed
  151. Qiu Z, et al. 2022. Cancer Discov. 12:502. PubMed
  152. Link CWM, et al. 2020. Front Immunol. 11:596772. PubMed
  153. Lin Z, et al. 2021. Stem Cells. 39:240. PubMed
  154. Takeuchi Y, et al. 2021. Sci Rep. 11:18679. PubMed
  155. Feng L, et al. 2019. Glia. 67:1434. PubMed
  156. Wagner AK, et al. 2017. Nat Commun. 8:15627. PubMed
  157. Yamasaki T, et al. 2018. J Virol. 92:e01458. PubMed
  158. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  159. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  160. Udumula MP, et al. 2021. Mol Metab. 53:101272. PubMed
  161. Nicolas-Boluda A, et al. 2021. eLife. 10:00. PubMed
  162. Lee YJ, et al. 2018. Front Microbiol. 9:83. PubMed
  163. Stotesbury C, et al. 2020. Aging Cell. 19:e13170. PubMed
  164. Wen J, et al. 2021. PLoS Pathog. 17:e1009738. PubMed
  165. Murenu E, et al. 2021. Mol Ther Methods Clin Dev. 20:587. PubMed
  166. Murenu E, et al. 2021. Int J Mol Sci. 22:. PubMed
  167. Karuppuchamy T, et al. 2020. Inflamm Bowel Dis. 216:26. PubMed
  168. Aikawa S, et al. 2020. Cell Death Differ. 1489:27. PubMed
  169. Heib T, et al. 2021. Cell Reports. 35(6):109102. PubMed
  170. Chevrier S, et al. 2021. Cell Reports Medicine. 2(1):100166. PubMed
  171. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  172. Sun Y, et al. 2015. Proc Natl Acad Sci U S A. 112: 10401-10406. PubMed
  173. Olver S, et al. 2005. Cancer Res. 66:571. PubMed
  174. Cole C, et al. 2018. Nucleic Acids Res. 46:e62. PubMed
  175. Andrews AR, et al. 2019. Cancer Cell Int. 0.955555556. PubMed
  176. Diao J, et al. 2018. J Immunol. 201:1306. PubMed
  177. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  178. Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed
  179. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  180. Zheng C, et al. 2021. J Extracell Vesicles. 10:e12109. PubMed
  181. Song M, et al. 2020. Nat Commun. 11:6298. PubMed
  182. Dubik M, et al. 2021. Front Neurosci. 15:682451. PubMed
  183. Hsieh YL, et al. 2019. Cell Reports. 29(8):2134-2143.e7. PubMed
  184. An Y et al. 2018. Cell reports. 25(3):702-714 . PubMed
  185. Chevrier S, et al. 2018. Cell Syst. 0.675. PubMed
  186. Kikuchi K, et al. 2018. J Immunol. 201:635. PubMed
  187. Larson–Casey JL, et al. 2019. J Clin Invest. 129:4962. PubMed
  188. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  189. K?stele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  190. Flores I, et al. 2021. Hum Mol Genet. Online ahead of print. PubMed
  191. Li Y, et al. 2021. Life Sci Alliance. 4:. PubMed
  192. Prabakaran T, et al. 2021. EBioMedicine. 66:103314. PubMed
  193. Li X, et al. 2020. J Clin Invest. 130:4182. PubMed
  194. Kang SH, et al. 2018. Oncoimmunology. 8:e1515057. PubMed
  195. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
  196. Fritz Y, et al. 2017. J Invest Dermatol. 137:696. PubMed
  197. Ito Y, et al. 2018. J Exp Med. 215:2617. PubMed
  198. Regan–Komito D, et al. 2017. Front Immunol. 1.459027778. PubMed
  199. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
  200. Torika N, et al. 2018. CNS Neurosci Ther. 24:231. PubMed
  201. Zhou N et al. 2018. Protein & cell. 10(2):87-103 . PubMed
RRID
AB_312784 (BioLegend Cat. No. 101201) AB_312785 (BioLegend Cat. No. 101202)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线